Therefore, although possible mechanisms by which overexpressed Her2 induces cell migration and invasion have already been extensively studied [25], [4], further elucidation of Her2-mediated invasive/metastatic mechanisms in lung cancer are necessary for the future development of therapeutics for this disease. The gene discussed is ERBB2; the disease is lung carcinoma.